Day: October 24, 2025

CALGARY, Alberta, Oct. 24, 2025 (GLOBE NEWSWIRE) — At the request of CIRO, Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. ABOUT CIELO Cielo Waste Solutions Corp. is a publicly traded company focused on transforming waste materials into high-value products. Cielo seeks to address global waste challenges while contributing to the circular economy and reducing carbon emissions. Cielo is fueling environmental change with a mission to be a leader in the wood by-product-to-fuels industry by using environmentally friendly, economically sustainable and market-ready technologies. Cielo is committed to helping society by providing environmental...

– First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation – – Second approved indication for Revuforj in less than one year further solidifies Syndax’s leadership in menin inhibition – – Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for R/R NPM1 mutated AML – – Syndax to host conference call today at 2:30 p.m. ET – NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved Revuforj® (revumenib) for the treatment of relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1) mutation in...

Honored for game-based learning innovations K12 ELA Village and K12 Coordinate Islands world for Minecraft Education RESTON, VA, Oct. 24, 2025 (GLOBE NEWSWIRE) — K12, a national leader in online learning for 25 years, has earned two Silver Medals from the International Serious Play Awards for its educational games, K12 ELA Village and K12 Coordinate Islands world for Minecraft Education. These student-centric games support interactive learning in English Language Arts and math according to grade-specific learning objectives.  Having served more than three million students nationwide, K12 helps students access high-quality education from home. K12’s award-winning curriculum integrates interactive games and learning environments that turn traditional lessons into hands-on experiences.  The K12 ELA Village immerses students in Grades...

Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (“Vivakor” or the “Company”) (Nasdaq: VIVK), an integrated energy infrastructure & environmental services company, today announced that it has entered into securities purchase agreements with a single fundamental institutional investor for the purchase and sale of 10,909,090 shares of its common stock and 5,000,000 pre-funded warrants in a registered direct offering, for gross proceeds of approximately $3.5 million, before deducting commissions and offering expenses. The closing of the offering is expected to occur on or about October 27, 2025, subject to the satisfaction of customary closing conditions. D. Boral Capital LLC is acting as exclusive placement agent for the offering. The proposed offering of the common stock described above is being offered by the Company...

Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets New preclinical data show that NBD1 stabilizers restored the half-life of F508del-CFTR up to wild-type levels WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced data presented at the 2025 North American Cystic Fibrosis Conference (NACFC) being held in Seattle, Washington October 22-25. “We are focused on advancing therapies that have the potential to make...

WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced updated preclinical data from the company’s potent and selective pan KRAS(ON) inhibitor in a poster presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics taking place in Boston, MA, October 22-26, 2025.  “We are excited today to share updated data from our pan KRAS(ON) program which demonstrates a potential best-in-class profile for our lead molecule,” said Andrew Robbins, Cogent’s President and Chief Executive Officer. “We look forward to advancing this program with the goal of filing an Investigational New Drug (IND) application to the U.S. Food and...

—Strategic Shift Focuses on Stablecoin Infrastructure and RWA TrackHong Kong, Oct. 24, 2025 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (NASDAQ: AXG) (“Solowin” or the “Company”), a leading financial services firm bridging traditional and digital assets, today announced the celebration of its first trade under the new ticker symbol “AXG” with a bell-ringing ceremony at the Nasdaq Stock Exchange. The event brought together long-term investors, strategic partners, and senior executives, marking a significant milestone in the Company’s strategic evolution. Addressing the audience, Dr. Haokang Thomas Zhu, director of Solowin, stated: “AXG stands for more than just a name — it reflects our bold vision to build a ‘Super App’ that seamlessly connects the traditional and digital financial worlds.” Through the advancement of its stablecoin infrastructure...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant Board of Directors decided to reduce its size and enhance corporate governance Muttenz, 24 October 2025 Clariant, a sustainability-focused specialty chemical company, today announced that the Board of Directors decided to reduce its size from eleven to eight members, right-sizing the Board to align with Clariant’s streamlined operations and addressing investor concerns on independence, tenure and gender diversity. In support of these efforts, five directors, Roberto Gualdoni, Geoffery Merszei, Eveline Saupper, Peter Steiner, and Konstantin Winterstein will not stand for reelection at the 2026 AGM on 1 April 2026. The Board will propose two new, independent Board members to the shareholders as appropriate ahead of the 2026 AGM. The Board’s independent Chairman, Ben van Beurden...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. (Ålesund, 24 October 2025) Reference is made to the stock exchange notices published by Hofseth BioCare ASA (“HBC” or the “Company“) earlier today regarding the launch of a private placement in the amount of between NOK 155m and NOK 181m and the partial divestment of shares in its U.S. subsidiary AecorBio Inc. (“AecorBio“). In conjunction with the Private Placement, the Company has resolved to divest 1,616,498 shares in AecorBio for approx. USD 5 million at a price per share of USD 3.0931,...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Hofseth BioCare ASA (“HBC” or the “Company“) today announces a contemplated private placement (the “Private Placement“) of between 86,096,132 and 100,638,889 new shares (“Offer Shares“) at a fixed price per share of NOK 1.80 (the “Offer Price“) corresponding to a total Private Placement size of between approx. NOK 155 million and approx. 181 million (the “Offer Size“). An amount fully covering the lower end of the Offer Size has already been placed...